Prospective randomized phase 2 trial of intensity modulated radiation therapy with or without oncolytic adenovirus-mediated cytotoxic gene therapy in intermediate-risk prostate cancer

Svend O. Freytag, Hans Stricker, Mei Lu, Mohamed Elshaikh, Ibrahim Aref, Deepak Pradhan, Kenneth Levin, Jae Ho Kim, James Peabody, Farzan Siddiqui, Kenneth Barton, Jan Pegg, Yingshu Zhang, Jingfang Cheng, Nancy Oja-Tebbe, Renee Bourgeois, Nilesh Gupta, Zhaoli Lane, Ron Rodriguez, Theodore DeweeseBenjamin Movsas

Resultado de la investigación: Articlerevisión exhaustiva

56 Citas (Scopus)

Huella

Profundice en los temas de investigación de 'Prospective randomized phase 2 trial of intensity modulated radiation therapy with or without oncolytic adenovirus-mediated cytotoxic gene therapy in intermediate-risk prostate cancer'. En conjunto forman una huella única.

Nursing and Health Professions

Medicine and Dentistry

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology